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Equine recurrent airway obstruction (RAO) has been used as a naturally
occurring model of human asthma. However, it is unknown whether there
is an early-phase response in RAO. The aim of this study was to
determine whether exposure to organic dust induces immediate changes
in lung function in RAO-affected horses, which could be mediated by
airway mast cells. Six RAO-affected horses in remission and six control
horses were challenged with hay-straw dust suspension by nebuliza-
tion. Total respiratory resistance at 1 Hz, measured by forced oscil-
lation, was increased from 0.62  0.09 cmH2O  l1 s (mean  SE) to
1.23  0.20 cmH2O  l1 s 15 min after nebulization in control horses
(P  0.023) but did not change significantly in the RAO group. Total
respiratory reactance at 1 Hz (P  0.005) was significantly lower in
the control horses (0.77  0.07 cmH2O  l1 s) than in the RAO
group (0.49  0.04 cmH2O  l1 s) 15 min after nebulization.
Bronchoalveolar lavage fluid (BALF) histamine concentration was
significantly elevated 10 and 20 min postnebulization in control
horses but not in RAO horses. Minimum reactance at 1 Hz in the early
postnebulization period significantly correlated with both prechal-
lenge BALF mast cell numbers (r  0.65, P  0.02) and peak
BALF histamine concentration postnebulization (r  0.61, P 
0.04). In conclusion, RAO horses, unlike human asthmatic patients,
do not exhibit an early-phase response. However, healthy control
horses do demonstrate a mild but significant early (20 min) phase
response to inhaled organic dust. This response may serve to decrease
the subsequent dose of dust inhaled and as such provide a protective
mechanism, which may be compromised in RAO horses.
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HUMAN ASTHMATIC PATIENTS develop an early-phase bronchocon-
striction within minutes of exposure to inhaled allergens.
Subsequently, a late asthmatic response with the continuation
of airway obstruction and the development of airway inflam-
mation can also be observed. Mast cells play an important role
in the early asthmatic response in both atopic and nonatopic
human asthma (9, 42). Allergen can activate mast cells by
cross-linking to high-affinity IgE receptors (FcRI) (40). The
activation of mast cells in response to inhaled allergen results
in the release of mast cell mediators, including histamine,
tryptase, chymase, cysteinyl leukotrienes, and prostaglandin
D2 (8, 14). These mediators can induce airway smooth muscle
contraction and the observed early-phase asthmatic response
(8, 14). Mast cells also release proinflammatory cytokines that,
together with other mast cell mediators, have the potential to
induce neutrophil and eosinophil infiltration and bronchocon-
striction involved in the late-phase asthmatic response (4, 8,
14). Activation of other mast cell receptors, in addition to
FcRI, such as KIT and complement component 3a receptor,
can also induce mast cell degranulation or amplify FcRI-
mediated mast cell activation (1, 3, 16, 21).
Recurrent airway obstruction (RAO) is an equine inflamma-
tory airways disease characterized by the development of a
late-phase response after exposure to organic dust, typically
from hay and straw. The late-phase response comprises airway
obstruction, airway inflammation, and airway hyperreactivity.
RAO has been suggested to be the most similar naturally
occurring disease in animals to human asthma (35) and has
been used as model of human asthma (2, 6, 17, 39).
Few studies have investigated the role of mast cells in the
pathogenesis of RAO. The degranulation of basophilic blood
cells and pulmonary mast cells in vitro in response to mold
spores has been demonstrated to be greater in cells derived
from RAO-affected horses than in those derived from control
horses (13, 19). Exposure to hay and straw for 5 h increased the
concentration of histamine in bronchoalveolar lavage (BAL)
fluid (BALF) in RAO-affected horses but not in control horses
(26). In contrast, a 30-min exposure to hay and straw did not
result in a significant increase in BALF histamine concentra-
tion (26). However, histaminase activity in the lung (22) may
have resulted in the degradation of histamine released during
an early-phase response by the time the 30-min sample was
collected. Mast cells that contain chymase rather than tryptase
appear to play a role in RAO, with the number of chymase-
positive mast cells correlating with the severity of neutrophil
infiltration (41). Mediators that are released from mast cells,
but not activated neutrophils, have been implicated in the
induction of bronchoconstriction in RAO (28). Levels of IgE
antibodies in response to mold allergens were greater in BALF
from RAO horses when in remission, as well as from those
demonstrating clinical signs of disease, compared with BALF
from healthy horses (18, 33). Enhanced production of IL-4 and
IL-13 may elevate allergen-specific IgE generation from B
cells during the early stages of RAO (20). IgE-mediated
reactions do not appear to be important in the late-phase
response in RAO (41).
The duration of organic dust exposure required before RAO-
affected horses develop clinical evidence of airway obstruction
varies from hours to days (15, 33), and clinical evidence of an
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early/immediate obstructive response is not apparent. How-
ever, the presence of a subclinical early response has not been
investigated. If a subclinical early-phase response to inhaled
dust does occur in RAO, the proinflammatory mediators re-
leased could exacerbate the late-phase response observed in
RAO (12, 23). Therefore, modulating or blocking an early-
phase response could be an important therapeutic opportunity.
We hypothesized that RAO-affected horses undergo an early-
phase subclinical airway obstruction mediated by mast cells
when exposed to organic dust. The aims of the study were to
determine whether an early-phase response to nebulized or-
ganic dust challenge occurs in RAO and whether the magni-
tude of an early-phase response is related to the late-phase
inflammatory response.
MATERIALS AND METHODS
The experimental protocol was approved by the Ethical Review
Committee of the Animal Health Trust and conformed to the Home
Office Animals (Scientific Procedures) Act 1986.
Animals. Six RAO-affected horses [4 geldings, 2 mares; mean age
14  0.7 (SE) yr and 510  12 kg body wt] and six control horses
(4 geldings, 2 mares; mean age 11  0.8 yr and 447  22 kg body wt)
were studied after between 15 and 20 wk at pasture. Exposure to
organic dust, by stabling with hay and straw, had previously been
demonstrated to induce reversible lung dysfunction in the RAO group
(increase in respiratory resistance from 0.73  0.06 to 1.47  0.12
cmH2O  l1 s) but not the control horses (from 0.67  0.06 to 0.66 
0.06 cmH2O  l1 s).
Study protocol. To control the dose of organic dust that each animal
received, horses were nebulized with a hay-straw dust suspension (29)
rather than exposed to hay and straw directly in a stable. Horses were
sedated 7 min before nebulization of hay-straw dust suspension. Two
minutes before nebulization (5 min after sedation), pulmonary func-
tion was measured. Horses were nebulized for 2 min with hay-straw
dust suspension. Five and 15 min after the end of nebulization (14 and
24 min after sedation, respectively), pulmonary function tests were
repeated. Ten minutes after the end of nebulization, BAL was per-
formed in either the right or left lung. Twenty minutes after nebuli-
zation, BAL was performed in the contralateral lung. Seven days
before nebulization, pulmonary function tests and BAL were per-
formed at the same time points as described above without nebuliza-
tion, to take into account any effects of sedation and BAL on lung
function and to determine baseline values of lung function, BALF
cytology, and histamine concentration. Twenty-four hours after neb-
ulization, pulmonary function tests and BAL were performed 5 min
after sedation. BAL was performed in an adjacent lung segment to that
lavaged previously.
Horses were sedated intravenously with romifidine (40 g/kg body
wt; Sedivet, Boehringer Ingelheim, Bracknell, UK) and butorphanol
(20 g/kg body wt; Torbugesic, Fort Dodge Animal Health,
Southampton, UK). Lung function was assessed by measuring total
respiratory resistance and reactance at 1.0, 2.0, 3.0, and 5.0 Hz by
forced oscillatory mechanics (11). BAL was performed by instilling
500 ml of 0.9% saline at 37°C as described previously (10) but
without local anesthesia of the conducting airways. BALF nucleated
cell counts were determined manually on a hemocytometer. BALF
differential cell counts were determined manually on cytospin prep-
arations, which were made within 15 min of collection, and stained
with hematoxylin and eosin. We have previously demonstrated that
there is good agreement in the mast cell percentages measured in
BALF when staining with hematoxylin and eosin (5.0  0.8%)
compared with Leishman’s stain (5.3  0.8%) in six control horses
and six RAO horses (unpublished observations). For histamine anal-
ysis, BALF was stored on ice before centrifugation at 1,000 g for 10
min at 4°C within 15 min of collection. BALF supernatant was stored
at 80°C until analysis. The concentration of histamine in BALF
supernatant was analyzed by ELISA (kit no. 59221; IBL Immuno-
Biological Laboratories, Hamburg, Germany).
Nebulization of hay-straw dust suspension. The hay-straw dust
suspension was produced as described previously (32) from batches of
hay and straw that had been demonstrated to induce airway obstruc-
tion in the group of RAO-affected horses, but not the control horses,
utilized in the present study. Two milliliters of hay-straw dust sus-
pension (100 mg/ml saline) were aerosolized with the use of a jet
nebulizer (Sidestream, Profile Respiratory Systems, Bognor Regis,
West Sussex, UK) and compressor (Corning, Halstead, Essex, UK),
with a calibrated output of 6 l/min (29). The aerosol generated was
transmitted into the inspiratory airflow of the horse via a closed
delivery system for 2 min at a nebulization rate of 0.5 ml/min.
Statistical analyses. Variables that were not normally distributed as
assessed by the Shapiro-Wilk’s normality test were transformed by
the natural logarithm, and the Shapiro-Wilk’s test was reapplied. This
approach resulted in the data sets approximating a normal distribution.
The effects of sedation and BAL on lung function tests and differ-
ences in cytology and histamine concentration in BALF collected
from the left and right lung seven days before nebulization were
investigated by one-way ANOVA. Measures of pulmonary function
were not affected by either sedation or BAL. Therefore, the effect of
organic dust nebulization on pulmonary function was assessed by
comparing data collected 5 min, 10 min, and 24 h after nebulization
with that measured 2 min before nebulization. Similarly, because
there were no differences between measures in left and right BALF
collected 7 days before nebulization, the two sets of data were pooled
and presented as the prenebulization baseline BALF data.
A nested ANOVA for repeated measures (repeated, replicated
two-way ANOVA) was used to determine the significance of the
effect of nebulization and differences between the RAO and control
groups. If significance was attained, further analyses were performed
with Tukey’s test for multiple comparisons. Correlations were inves-
tigated by Spearman’s Rank test. Results were considered to be
significant at P  0.05. Data are presented as means  SE. Statistical
analyses were performed with StatMost for Windows (DataMost, Salt
Lake City, UT).
RESULTS
BALF cytology. BALF cytology was not significantly altered
10 or 20 min after challenge with organic dust in RAO-affected
horses (Table 1). In the control group, BALF lymphocyte
counts were decreased 10 min postnebulization (P  0.016),
and BALF total nucleated cell counts and macrophage counts
were decreased 10 min (P  0.003 and P  0.007, respec-
tively) and 20 min (P  0.022 and P  0.020, respectively)
postnebulization and returned to baseline values within 24 h
(Table 1). Twenty-four hours after nebulization, BALF neu-
trophil counts were significantly higher than before nebuliza-
tion in the RAO group (P  0.0001) but not in the control
group (Table 1).
BALF histamine concentration. In the control group, the
concentration of histamine in BALF was higher 10 min (P 
0.027) and 20 min (P  0.036) after nebulization compared
with prenebulization (Fig. 1). BALF histamine concentration
was not significantly altered after nebulization in the RAO
group (Fig. 1).
Pulmonary function. Neither total respiratory resistance nor
reactance at 1, 2, 3, or 5 Hz was significantly changed by
organic dust nebulization in the RAO group (Figs. 2 and 3).
Total respiratory resistance at 1 Hz (P  0.023) and 2 Hz (P 
0.05) was increased 15 min after nebulization in control horses
(Fig. 2). Total respiratory resistance at 3 and 5 Hz was not
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changed after nebulization in control horses (Fig. 2). Total
respiratory reactance at 1 Hz (P  0.005) and 2 Hz (P  0.03)
was significantly lower in the control horses than in the RAO
group 15 min after nebulization (Fig. 3). Reactance at 3 Hz was
lower 5 and 15 min postnebulization compared with prenebu-
lization in the control group (P  0.035 and P  0.015,
respectively; Fig. 3). Resonant frequency was not altered by
organic dust nebulization in the RAO group (Fig. 4). In the
control group, resonant frequency was significantly increased
15 min postnebulization compared with before nebulization
(P  0.025) and 24 h postnebulization (P  0.009) (Fig. 4).
Correlations. The most negative reactance at 1 Hz measured
at either 5 or 15 min after nebulization for each horse corre-
lated inversely with the BALF mast cell number before nebu-
lization (r  0.65, P  0.02; Fig. 5), and the peak BALF
histamine concentration 10 or 20 min after nebulization (r 
0.61, P  0.04). BALF mast cell number prenebulization
also correlated with peak BALF histamine concentration post-
nebulization (r  0.89, P  0.0001). BALF neutrophil number
24 h postnebulization was not correlated with BALF mast cell
number before exposure, peak BALF histamine concentration
10 or 20 min postnebulization, or total respiratory reactance or
resistance 5 or 15 min after nebulization.
DISCUSSION
In contrast to our hypothesis, an early-phase response to
organic dust consisting of decreased lung function and in-
creased BALF histamine concentration was identified in con-
trol horses rather than in the RAO group. The results also differ
from studies in human subjects, where asthmatic but not
nonasthmatic individuals demonstrate an early-phase response
to inhaled allergen.
The study design included sedation before nebulization of
the organic dust. This procedure may have decreased the
effects of organic dust on lung function. The measurements
taken before nebulization were performed not only to deter-
mine baseline lung function but also to account for any effects
of sedation and the procedure of BAL on lung function. In the
control horses and RAO-affected horses in remission before
nebulization, sedation and BAL did not result in significant
Table 1. Bronchoalveolar lavage fluid cytology in control horses and horses affected by RAO
before and after nebulization of organic dust
Time After Nebulization
Pre 10 min 20 min 24 h
Total nucleated cell count, number/l
Control 27529 12228* 14223* 39557
RAO 28083 283111 16346 523232
Macrophage, %
Control 536 527 4912 5013
RAO 498 538 455 3411
Lymphocyte, %
Control 397 393 419 389
RAO 448 428 495 3712
Neutrophil, %
Control 22 21 32 66
RAO 22 22 32 2611*†
Mast cell, %
Control 62 65 65 43
RAO 42 32 33 21
Macrophage count, number/l
Control 14517 6415* 669* 20437
RAO 13943 15564 7221 14749
Lymphocyte count, number/l
Control 11015 4710* 6012 15128
RAO 12742 11746 8226 18670
Neutrophil count, number/l
Control 61 21 41 207
RAO 41 42 41 181114*
Mast cell count, number/l
Control 141 83 104 116
RAO 92 72 41 72
Values are means  SE. RAO, recurrent airway obstruction. *Significantly different compared with prenebulization (Pre) (P  0.02). †Significantly different
compared with control horses (P  0.003).
Fig. 1. Concentration of histamine in bronchoalveolar lavage fluid (BALF)
from control horses (n  6; open bars) and horses affected by recurrent airway
obstruction (n  6; closed bars) before (Pre) and after nebulization of organic
dust. Data are means  SE. *Significantly different compared with Pre (P 
0.04).
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changes in lung function at the time points measured. How-
ever, in RAO-affected horses with airway obstruction, sedation
with 2-agonists has been demonstrated to decrease airway
resistance (5).
The technique of forced oscillation was used to measure
lung function instead of simultaneous measures of transpulmo-
nary pressure and flow rate, as the forced oscillation technique
is noninvasive and can identify frequency-dependent changes
(44). Lung function measurements with the two techniques
have previously been demonstrated to closely correlate (43).
The forced oscillation technique not only measures the reac-
tance and resistance of peripheral intrathoracic airways but also
of extrathoracic airways, including the larynx. Alterations in
lung function measured in control horses after nebulization
may therefore not be a result of small airway obstruction.
However, the observations of 1) a negative frequency depen-
dence in total respiratory resistance and 2) a more negative
reactance at frequencies below resonant frequency in control
horses 15 min postnebulization are consistent with distal small
airway obstruction rather than upper airway obstruction in
humans (34). Saline nebulization was not used as a control.
However, we have previously determined that lung function is
not altered up to 10 min after saline nebulization in either
control or RAO horses (Deaton and Marlin, unpublished ob-
servations).
Despite the measurement of statistically significant de-
creases in lung function in the control group after organic dust
nebulization, no clinical signs of increased respiratory effort
(such as increased respiratory rate, abdominal effort, or nasal
flaring) were observed, suggesting that the degree of airway
obstruction was mild. It is plausible that the early-phase re-
sponse of the control horses may be a protective mechanism. In
healthy human subjects, the induction of bronchoconstriction
before inhalation of Teflon particles significantly reduced the
fraction of particles deposited in the peripheral airways and
alveoli (36). Furthermore, the fraction of particles deposited in
the peripheral airways and alveoli was considerably diminished
by only a relatively small degree of bronchoconstriction (36).
Therefore, in control horses, after a mild early-phase airway
obstruction, the subsequent dose of inhaled organic dust reach-
ing the alveoli would be decreased, which would reduce the
stimulus for the late-phase response. The absence of a signif-
icant early-phase response in RAO-affected horses would con-
versely render them more susceptible to higher dust deposition
in the alveoli and peripheral airways and consequently result in
an exaggerated late-phase response. The deficiency of a sig-
nificant early-phase response in RAO horses may reflect the
absence of sufficient numbers of pulmonary mast cells to
produce adequate amounts of mediators to induce airway
smooth muscle contraction. Combining data from both the
control and RAO groups, decrements in lung function mea-
sured during the early phase were associated with the BALF
histamine concentration and BALF mast cell number. Mast
cells can release a range of mediators in addition to histamine,
such as 5-hydroxytryptamine and leukotriene D4, which are
also able to enhance airway smooth muscle contraction in the
horse by augmenting cholinergic responses (28).
The decrease in lung function observed in the control horses
may not solely be explained by airway smooth muscle con-
traction. In human asthmatic patients, local allergen rapidly
induced hyperemia, edema, and bronchial narrowing (27). In a
guinea pig model of human asthma, increased mucous secre-
Fig. 2. Total respiratory resistance in control
horses (n  6; open bars) and horses affected by
recurrent airway obstruction (n  6; closed bars)
before (Pre) and after nebulization of organic
dust. Data are means  SE. *Significantly dif-
ferent compared with Pre and 24 h post (P 
0.05).
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tion and pulmonary edema occurred immediately after expo-
sure to allergen in sensitized animals (38). Pulmonary edema
appeared to reflect airway epithelial cell disruption induced by
inflammatory cells (38). In the present study, there was no
evidence for mucous accumulation or inflammatory cell infil-
tration into the airways in control horses after nebulization of
organic dust.
The severity of airway inflammation induced by organic dust
is dose dependent in both control and RAO horses, and the
threshold for induction of inflammation is far greater in the
control group (29). The dose of dust suspension utilized in the
present study was the highest dose administered to RAO horses
by Pirie et al. (29). Three different hay dust suspensions
induced marked airway inflammation in RAO horses when
administered at the dose used in the present study (29). For
BAL performed 24 h after nebulization, an adjacent airway
was lavaged to that sampled 10 min after nebulization to
minimize the effects of the previous BAL on BALF cytology.
Sweeney et al. (37) demonstrated that any effects of a BAL on
BALF cytology from an adjacent airway were eliminated
within 48 h. Repeating the BAL procedure after 6 and 24 h on
different lung regions did not significantly alter BALF cytol-
ogy in healthy horses (25). Similarly, in the present study,
BALF neutrophil numbers were only significantly elevated in
the RAO group and not in the control horses 24 h after
Fig. 3. Total respiratory reactance in control
horses (n  6; open bars) and horses affected by
recurrent airway obstruction (n  6; closed bars)
before (Pre) and after nebulization of organic
dust. Data are means  SE. *Significantly dif-
ferent compared with Pre and 24 h post (P 
0.04). #Significantly different compared with
control horses (P  0.03).
Fig. 4. Resonant frequency in control horses (n  6; open bars) and horses
affected by recurrent airway obstruction (n  6; closed bars) before (Pre) and
after nebulization of organic dust. Data are means  SE. *Significantly
different compared with Pre and 24 h post (P  0.025).
Fig. 5. Correlation between the number of mast cells in BALF before nebu-
lization and minimum total respiratory reactance at 1 Hz either 5 or 10 min
after nebulization of organic dust in control horses (E) and horses affected by
recurrent airway obstruction (F) (r  0.65, P  0.02).
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nebulization and BAL of an adjacent airway. Therefore, the
airway inflammation induced 24 h after nebulization in the
RAO group is likely to have been induced by organic dust, in
agreement with Pirie et al. (29).
The absence of a significant correlation between measures of
lung dysfunction associated with the early-phase response and
BALF neutrophil numbers 24 h postnebulization suggests that
the lack of an early-phase airway obstruction is not the pre-
dominant factor in RAO-affected horses developing a late-
phase inflammatory response. However, the power of the study
may have been insufficient to determine a significant correla-
tion. In addition, the airway inflammation may have partially
resolved by 24 h as neutrophil infiltration into the pulmonary
epithelial lining fluid occurs within 6 h of organic dust nebu-
lization in RAO horses (29). Inhaled dust may induce the
late-phase neutrophilic infiltration in RAO observed in the
present study by enhancing the production of proinflammatory
mediators from a range of cell types in addition to mast cells,
such as alveolar macrophages, lymphocytes, and airway epi-
thelial cells (6, 7, 24, 41). Reduced numbers of macrophages
and lymphocytes were evident in control horses immediately
after challenge. This reduction was unanticipated, and we have
no data to suggest a mechanism for such effects. The inflam-
matory process is likely to be complex, given the diverse
composition of organic dust. Components of organic dust have
synergistic effects on the development of airway inflammation
when inhaled together (30, 31).
Another important component of the late-phase response in
RAO is the induction of reversible airway obstruction. How-
ever, in the present study, increases in resistance and decreases
in reactance were not detected 24 h after nebulization com-
pared with baseline measurements in either RAO or control
horses. Similarly Pirie et al. (29) determined that dynamic lung
compliance, maximum change in transpulmonary pressure, and
a clinical score of respiratory effort were not altered in RAO
horses 5 h after nebulization of hay dust suspension. These
findings are likely to reflect the short duration of the challenge
compared with continuous exposure to organic dust by stabling
with hay and straw. Horses were exposed to organic dust by
nebulization of a hay-straw dust suspension rather than stabling
with hay and straw so that the dose of organic dust that each
horse received could be standardized. To confirm that the
early-phase response in control horses has a protective effect
on lung function, horses would have to be exposed to organic
dust after the induction of the early-phase response.
In conclusion, exposure to organic dust results in a mild
early-phase airway obstruction in healthy horses but not in
horses affected by RAO. This early-phase response appears to
be regulated by mast cell-derived mediators and may be a
protective mechanism to decrease the dose of organic dust
reaching the peripheral airways.
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